![Caroline Loew](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Loew
Keine laufenden Positionen mehr
Profil
Caroline J.
Loew worked at Bristol Myers Squibb Co. as Vice President & Head-Research from 2015 to 2018.
From 2018 to 2022, Dr. Loew was President, Chief Executive Officer & Director at Glympse Bio, Inc. Dr. Loew served as Director at Mural Oncology Plc in 2023.
Dr. Loew completed undergraduate and doctorate degrees at Imperial College London.
Ehemalige bekannte Positionen von Caroline Loew
| Unternehmen | Position | Ende |
|---|---|---|
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Vorstandsvorsitzender | 01.08.2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.10.2018 |
Ausbildung von Caroline Loew
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Health Technology |
